An Evaluation of the Pharmacological Interaction of Lopinavir 800mg - Ritonavir 200mg Combination and Rifampin in Subjects Presenting Tuberculosis, With Contraindication for Antiretroviral Regimens Including Efavirenz.

Trial Profile

An Evaluation of the Pharmacological Interaction of Lopinavir 800mg - Ritonavir 200mg Combination and Rifampin in Subjects Presenting Tuberculosis, With Contraindication for Antiretroviral Regimens Including Efavirenz.

Completed
Phase of Trial: Phase IV

Latest Information Update: 21 May 2015

At a glance

  • Drugs Lopinavir/ritonavir (Primary) ; Isoniazid; Pyrazinamide; Rifampicin
  • Indications HIV infections; Tuberculosis
  • Focus Pharmacokinetics
  • Acronyms A06-295
  • Most Recent Events

    • 18 May 2015 Status changed from recruiting to completed as per ClinicalTrials.gov record.
    • 24 Jun 2009 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
    • 25 Oct 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top